Windsor Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-919
Closed -$229K 215
2021
Q1
$229K Sell
919
-2,928
-76% -$699K 0.05% 185
2020
Q4
$884K Sell
3,847
-68
-2% -$15.7K 0.23% 91
2020
Q3
$880K Buy
3,915
+158
+4% +$39.1K 0.26% 86
2020
Q2
$886K Buy
3,757
+148
+4% +$33.8K 0.28% 79
2020
Q1
$732K Buy
3,609
+994
+38% +$217K 0.29% 80
2019
Q4
$630K Sell
2,615
-92
-3% -$20.3K 0.23% 97
2019
Q3
$512K Sell
2,707
-719
-21% -$138K 0.22% 110
2019
Q2
$638K Buy
3,426
+91
+3% +$16.3K 0.28% 97
2019
Q1
$634K Buy
3,335
+308
+10% +$58.8K 0.36% 85
2018
Q4
$589K Buy
3,027
+644
+27% +$126K 0.4% 76
2018
Q3
$494K Buy
2,383
+285
+14% +$56.2K 0.32% 87
2018
Q2
$387K Buy
+2,098
New +$371K 0.3% 87

Other funds holding AMGN

Windsor Wealth Management's AMGN Position: Q2 2021 in Review

Windsor Wealth Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 919 shares — an estimated $229K sold.

Windsor Wealth Management first reported a position in AMGN in Q2 2018 and held it in 12 quarters. The position peaked at $886K in Q2 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Windsor Wealth Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Windsor Wealth Management sold 919 Amgen shares in Q2 2021, an estimated $229K.
  • Windsor Wealth Management first reported a position in Amgen in Q2 2018 and held it in 12 quarters.
  • Windsor Wealth Management's Amgen position peaked at $886K in Q2 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Windsor Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.